American Fusion Inc. (OTC: AMFN) is bolstering its scientific and intellectual property foundations as it advances its Texatron Fusion Engine program. The company recently announced the appointment of Dr. Noah D’Amico, a physicist and engineer at Texas Tech University, as a Strategic Advisor. This move comes as American Fusion prepares for further evaluations of its Texatron platform at Texas Tech and seeks to enhance its diagnostics and engineering capabilities.
Dr. D’Amico, who continues his work at Texas Tech and BlankSlate Innovation, brings expertise in nuclear diagnostics, neutron detection, radiation measurements, vacuum-system design, and AI-based analysis of CR-39 nuclear particle tracks. He earned his Ph.D. in Physics from Texas Tech in 2026, with a dissertation focused on advanced diagnostic techniques. His addition is expected to strengthen the company's ability to analyze and refine the Texatron system during its testing phases.
In tandem with the appointment, American Fusion has filed six additional U.S. patent applications, bringing its total to 82. This expansion of its intellectual property portfolio underscores the company's commitment to protecting its innovations in fusion energy technology. The patents cover various aspects of the Texatron platform, including plasma control, magnetic field containment, and fuel delivery systems.
The company has also initiated testing of its Texatron platform at Texas Tech University. After completing initial laboratory preparations and verifying its remote ignition system, American Fusion is moving into a more active testing phase. The next stage will examine subsystems such as plasma and magnetic-field control, ignition, fuel delivery, and electronic components. These tests are critical to validating the performance and feasibility of the Texatron design.
This strategic expansion comes at a pivotal time for the fusion energy sector, which is attracting significant investment and interest as a potential source of clean, abundant power. American Fusion's progress in building its scientific team and IP portfolio positions it to compete in this rapidly evolving field. The company's focus on practical testing and diagnostics suggests a methodical approach to overcoming the technical challenges of fusion energy.
For investors and industry observers, these developments signal that American Fusion is actively advancing its technology beyond the conceptual stage. The involvement of academic experts like Dr. D’Amico adds credibility and access to cutting-edge research. Meanwhile, the growing patent portfolio provides a defensive moat and potential licensing opportunities.
As American Fusion continues to test and refine its Texatron platform, the outcomes will be closely watched. Successful demonstration of key subsystems could pave the way for further funding and partnerships. The company's commitment to rigorous testing and IP protection is a positive indicator of its long-term viability in the competitive fusion landscape.
More information about American Fusion's latest news and updates is available in the company's newsroom at https://nnw.fm/AMFN.
